Home > Healthcare > Medical Devices > Implantable Devices > Hip Replacement Market
Hip Replacement Market size exceeded USD 7.5 billion in 2022 and is forecast to register around 3.5% CAGR between 2023 and 2032. Increasing number of road accidents and hip injuries across the world is fueling the industry growth. The surge in the number of hip arthroplasty procedures is accelerating the acceptance of hip replacement devices.
Hip replacement devices or implants are medical devices used to recover mobility and reduce pain associated with arthritis and other hip disorders. Each hip implant system has different device design features such as material, shape, fixation materials, etc. The adoption of hip replacement surgery is increasing due to its high success and low complication rate. Many hip replacements last for about 15 years based on material, manufacturer, and types of joint replacement.
Report Attribute | Details |
---|---|
Base Year: | 2022 |
Hip Replacement Market Size in 2022: | USD 7 billion |
Forecast Period: | 2023 to 2032 |
Forecast Period 2023 to 2032 CAGR: | 3.5% |
2032 Value Projection: | USD 10 Billion |
Historical Data for: | 2018 to 2022 |
No. of Pages: | 280 |
Tables, Charts & Figures: | 592 |
Segments covered: | Product, Material, Fixation Material, Inserts, End-use and Region |
Growth Drivers: |
|
Pitfalls & Challenges: |
|
However, the hip replacement devices are classified as a Class III medical device that is subject to stringent regulations and compliances. As a result, these devices are regulated by the U.S. FDA. A premarket approval (PMA) is needed for class III devices before their commercial distribution. The manufacturer is required to get approval under section 515 of the act that comprises of FDA's issuance of approving the application for premarket approval (PMA) for the device. Moreover, the European Union Commission has revised the medical device regulation that substitutes the current medical device directive. As per the new regulation, these devices are classified as class 3 devices that refer to a class of high-risk devices that are subject to stringent compliances. Hence, stringent regulations will impede the hip replacement market growth in the future.
Rising technological developments across the world will stimulate the market expansion. Recent innovations in surgical technique and instrumentation enables the surgeons to perform hip replacement procedures through smaller incision on the skin. This facilitates quicker recovery and faster rehabilitation. Furthermore, recently developed Hana Table, a unique patient positioning tool facilitates early recovery for hip replacement patients. This table aids secure the patient during surgery, makes exposure of the hip joint easier, and enables proper implant positioning. Similarly, the advent of custom implants has been beneficial for healthcare providers as well as patients. Custom implants are tailored as per patient requirements and provide better fitting, broader ranges of movement and higher satisfaction. Industry players are emphasizing on research and development activities to offer advanced products with better effectiveness.
The primary hip replacement devices segment held more than USD 5.49 billion in 2022. The benefits offered by primary hip replacement procedures include improved function, pain relief, and advanced quality of life among others resulting in augmenting the segment revenue in foreseeable future. Additionally, manufacturers in the market offer a comprehensive portfolio of technologically advanced hip products coupled with a focus on specific requirements of individual patients. The notable growth rate of the segment is owing to developments in hip joint replacement surgical methods that reduce the risk of chronic health conditions and allow the removal of the diseased bone & cartilage. The surging adoption of hip replacement devices is due to the high success rate of primary hip replacement surgery.
Based on material, the hip replacement market is classified into metal-on-plastic, ceramic-on-plastic, ceramic-on-ceramic, and others. The metal-on-plastic segment accounted for more than USD 4.22 billion in 2022. The significant revenue share is owing to the advantages metal-on-plastic devices offer that includes durability, precise outcome, affordable alternative, etc. Metal-on-plastic hip replacement devices are a better alternative for less active patients and are the most regularly used hip replacement implants. Furthermore, several other benefits such as technological advancements, fewer complications, and lesser wear particles are increasing its adoption. The most used metal and plastic include stainless steel & titanium and polyethylene, respectively. It is the widely used artificial hip component material chosen by surgeons owing to its advantages. For instance, as per the recent research article, metal-on-plastic hip implant may advance hip resurfacing results and offer good long-term outcomes in aged patients.
Hip replacement market from cemented fixation segment is anticipated to reach over USD 762 million by 2032. This steady growth rate is due to benefits such as high survival rate, forms an interlocking fit between implant & bone, and allows the bone to grow onto the implant over time. For instance, the survival rate of cemented fixation used at 10 years is around 96% in patients aged over 75 years. Cemented fixation uses fast-drying bone cement to attach the patient's natural bone and the prosthetic joint component. A small amount of antibiotic material can be added to the bone as the cement dries within 10 minutes of application thus, helps to reduce the risk of post-surgical infection.
Based on inserts, the hip replacement market is segmented as cross-linked polyethylene inserts, antioxidant polyethylene inserts, and non-antioxidant polyethylene inserts. The cross-linked polyethylene inserts segment is anticipated to reach over USD 3.43 billion by 2032. The advantages of cross-linked polyethylene include reduced osteolysis, offers excellent clinical outcomes, and implant survivorship among others resulting in augmenting the segment revenue in foreseeable future. These inserts are developed precisely to decrease polyethylene wear and subsequent wear debris-induced osteolysis. For instance, clinical studies have demonstrated that cross-linked polyethylene inserts have a high success rate in primary hip arthroplasty.
Moreover, in hip replacement procedures, this insert is comparatively insensitive to femoral head size, allows the surgeon to use large femoral heads to strengthen hip stability and decrease post-operative complications. According to the article published by the National Center for Biotechnology Information (NCBI), cross-linked polyethylene inserts have been widely adopted and are highly effective 15 years after the surgery in a young & active individual. Hence, owing to these attributes the industry is anticipated to witness a lucrative growth in the coming years.
Hip replacement market from hospitals segment accounted for more than 83% revenue share in 2022 and will foresee a similar trend during the forecast timeframe. High adoption of advanced hip replacement devices providing improved outcomes will drive the patient preference for hospitals. Increasing hospital admissions with several hip disorders along with the availability of trained healthcare professionals will impel the demand for hip replacement devices in the hospitals. Additionally, hospitals provide continuous monitoring after surgery, design exercise to restore strength, work closely with patients, and offer physical therapies. Therefore, patient preference for a well-equipped emergency orthopedic surgery department will fuel the segment revenue. As a result, well-equipped hospitals will be preferred by the patients.
North America hip replacement market is anticipated to expand at 2.8% CAGR and foresee similar growth trend in the coming years. This high revenue share is mainly attributed to the favourable reimbursement scenario, growing adoption of orthopedic surgeries, and rising burden of hip related ailments in the regions among others. According to the Agency for Healthcare Research and Quality, over 450,000 primary hip replacements are performed every year in the U.S. Hip injuries as a result of road accidents and falls are a common cause of hip dislocation and require hip replacement. Hence, the above-mentioned factors will significantly propel the regional market forecast in the coming years.
Some of the major market players operating in the hip replacement industry are:
The major market players focus on strategic collaborations, mergers, and partnerships to expand their market and launch of new products to strengthen the product portfolio. Furthermore, these players are investing in research and development activities that allow these players to garner maximum market share.
The COVID-19 pandemic had adversely impacted the number of hip arthroplasty procedures. High risk of COVID-19 infection involved during the surgical procedure along with rising COVID-19 patient admissions in the hospitals were one of the prime factors resulted in declining surgical procedures. However, the hip replacement industry observed significant growth due to the decreasing number of COVID-19 patients in some regions and implementation of standard operating protocols in healthcare facilities. The government initiatives for providing clinical emergency care to patients suffering from osteoarthritis had sustained the revenue growth. Despite the moderate negative impact that hip replacement industry had witnessed for some period, it is expected to foresee tremendous growth in the future.
The hip replacement market research report includes an in-depth coverage of the industry with estimates & forecast in terms of revenue in USD (million) and volume (units) from 2018 to 2032 for the following segments:
Click here to Buy Section of this Report
By Product
By Material
By Fixation Material
By Inserts
By End-use
The above information is provided for the following regions and countries: